Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-046839
Filing Date
2024-11-19
Accepted
2024-11-19 16:38:04
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1291408
2 ex31-1.htm EX-31.1 14511
3 ex31-2.htm EX-31.2 14446
4 ex32-1.htm EX-32.1 5495
5 ex32-2.htm EX-32.2 5544
6 form10-q_001.jpg GRAPHIC 14209
  Complete submission text file 0001493152-24-046839.txt   5849457

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE tvgn-20240930.xsd EX-101.SCH 40640
8 XBRL CALCULATION FILE tvgn-20240930_cal.xml EX-101.CAL 54067
9 XBRL DEFINITION FILE tvgn-20240930_def.xml EX-101.DEF 252199
10 XBRL LABEL FILE tvgn-20240930_lab.xml EX-101.LAB 384966
11 XBRL PRESENTATION FILE tvgn-20240930_pre.xml EX-101.PRE 332052
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 765059
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41002 | Film No.: 241476785
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)